Melanoma is one of the most dangerous forms of skin cancer. There are approximately 75,000 new cases of melanoma diagnosed and 9,000 melanoma related deaths in the United States each year.
Melanoma may appear on normal skin or could start as a mole that changes in appearance. Melanomas that start on the skin are called cutaneous melanomas. Less commonly, melanoma can originate in other locations such as the eyes (ocular or uveal melanoma) or lining surfaces such as the sinuses or vaginal tract (mucosal melanoma). Over 90 percent of melanomas are caused by mutations in DNA of skin cells called melanocytes, which produce the pigment melanin.
There are various types and stages, and symptoms of cutaneous melanoma.
Specific types of cutaneous melanomas include the following:
At the time of your diagnosis, your physician will stage your melanoma based one the following criteria:
A skin lesion may be melanoma if it exhibits certain telltale characteristics, including:
Risks for developing cutaneous melanoma include:
With the incidence of melanoma increasing, it is of the utmost importance that you are proactive in getting screened diagnosed for any skin abnormalities. While the median age of diagnosis is 59 years, whatever age you are, you can develop melanoma.
Treatments for melanoma may incorporate both surgical procedures such as wide excision, sentinel lymph node biopsy, and completion lymph node dissection, and medications such as chemotherapies and immune therapies for stage II, III, and IV melanomas.
The preferred treatment starts with excision, in which the surgeon numbs the skin, then cuts out the skin cancer and a section of surrounding skin that looks normal. Most excisions are performed in a physician’s office. Specimens of the tumor are sent to a dermatopathologist for analysis.
In addition to surgery to treat melanomas, we offer immunotherapy, radiation therapy, and systemic chemotherapy therapy. Immunology uses the patient’s own immune system to fight the cancer. The patient applies a cream (its generic name is Imiquimod) to the skin as directed. Radiation therapy works by gradually destroying the cancer cells through repeated exposure to radiation. A patient may receive 15 to 30 treatments. Systemic chemotherapy goes throughout the body to cancer that spreads beyond the skin to kill the cancer cells. This medicine, containing a mix of chemicals, can be swallowed, taken by injection, or intravenously infused. As the medicine travels through the body, it kills the cancer cells. Because it also destroys some normal cells, a patient can experience side effects, such as vomiting and hair loss. When the chemotherapy stops, the side effects usually do.
Surgical Procedures to Treat Melanoma
Medications to Treat Melanoma
To Treat Deep Stage II and Stage III Melanoma
To Treat Stage IV Melanoma
To understand how this treatment works, consider what happens to your immune system when you develop an infection. Your immune system is activated to fight the infection. Once the infection is treated, the immune system then starts to shut itself off. In order to do this, a type of immune cell called the suppressor T-cell, which suppresses the immune system, starts to express on its surface CTLA-4, which then binds to proteins such as B7 found on other immune cells to suppress their activity. Ipilimumab binds to CTLA-4 and prevents CTLA-4 from doing its job as it can no longer bind effectively to other proteins such as B7. As such, the immune system is not suppressed and remains active.
The response rate to treatment with vemurafenib in patients whose melanoma expresses a V600E BRAF mutation is approximately 50 percent, and a significant overall survival benefit is seen with this treatment. These benefits are not seen in melanomas lacking mutations in BRAF.